↓ Skip to main content

RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer

Overview of attention for article published in BMC Cancer, April 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer
Published in
BMC Cancer, April 2021
DOI 10.1186/s12885-021-08078-y
Pubmed ID
Authors

Ramon Gonzalez Manzano, Ana Catalan-Latorre, Antonio Brugarolas

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 17%
Student > Doctoral Student 2 8%
Student > Master 2 8%
Student > Ph. D. Student 1 4%
Other 1 4%
Other 2 8%
Unknown 12 50%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 17%
Medicine and Dentistry 4 17%
Agricultural and Biological Sciences 1 4%
Unknown 15 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2023.
All research outputs
#7,949,000
of 25,376,589 outputs
Outputs from BMC Cancer
#2,115
of 8,962 outputs
Outputs of similar age
#161,645
of 434,007 outputs
Outputs of similar age from BMC Cancer
#60
of 320 outputs
Altmetric has tracked 25,376,589 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 8,962 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,007 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 320 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.